Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients.
Hiroaki IwataArtem VorobyevHiroshi KogaAndreas ReckeDetlef ZillikensCatherine Prost-SquarcioniNorito IshiiTakashi HashimotoPardis-Sadat Tabatabaei-PanahPublished in: Orphanet journal of rare diseases (2018)
Within the limitations of the study, we here document the clinical and immunopathological characteristics and treatment outcomes in a large cohort of EBA patients. The observed associations of single drugs with treatment outcome may serve as a guide to develop clinical trials.